Suchergebnisse - "Akram, Javed"

PubPharm (151)

1

Author Correction : Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials

enthalten in: Nature communications | 2024

von Axfors, C. | Schmitt, A. | Janiaud, P. | +91

ErratumFor: Nat Commun. 2021 Apr 15;12(1):2349. - PMID 33859192

2

Theoretical investigation of dynamics and concurrence of entangled [Formula : see text] and anti-[Formula: see text] symmetric polarized photons

enthalten in: Scientific reports | 2023

von Akram, J. | Zheng, C.

3

Efficacy and Safety of the RBD-Dimer-Based Covid-19 Vaccine ZF2001 in Adults

enthalten in: The New England journal of medicine | 2022

von Dai, L. | Gao, L. | Tao, L. | +128

4

SARS-CoV-2 variants of concern dominate in Lahore, Pakistan in April 2021

enthalten in: bioRxiv.org | 2022

von Sarwar, M. | Yasir, M. | Alikhan, N. | +16

5

Protocol of Pakistan randomized and observational trial to evaluate coronavirus treatment among newly diagnosed patients with COVID-19 : Azithromycin, Oseltamivir, and Hydroxychloquine

enthalten in: Pakistan journal of medical sciences | 2022

von Azhar, S. | Akram, J. | Shahzad, M. | +2

6

Correction to : Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection: A structured summary of a study protocol for a randomized controlled trial

enthalten in: Trials | 2022

von Akram, J. | Azhar, S. | Shahzad, M. | +2

ErratumFor: Trials. 2020 Aug 8;21(1):702. - PMID 32771032

7

Correction to: Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection: A structured summary of a study protocol for a randomized controlled trial

enthalten in: Trials | 2022

von Akram, J. | Azhar, S. | Shahzad, M. | +2

8

Correction to: Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection: A structured summary of a study protocol for a randomized controlled trial

enthalten in: Trials | 2022

von Akram, J. | Azhar, S. | Shahzad, M. | +2

9

From Molecular Pathology of COVID 19 to Nigella Sativum as a Treatment Option : Scientific Based Evidence of Its Myth or Reality

enthalten in: Chinese journal of integrative medicine | 2022

von Atif, M. | Naz, F. | Akhtar, J. | +5

10

Epidemiology, Clinico-Pathological Characteristics, and Comorbidities of SARS-CoV-2-Infected Pakistani Patients

enthalten in: Frontiers in cellular and infection microbiology | 2022

von Omer, S. | Gondal, M. | Usman, M. | +13

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[16]